Glenn T. Stebbins, PhD, is a Professor Emeritus in the Movement Disorders Section of the Department of Neurological Sciences at Rush University Medical Center, Chicago, Illinois. His main research interest is the construction and validation of clinical outcome assessments for use in movement disorders which has resulted in the development of over 15 rating scales including such standard assessments as the Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and the Unified Dyskinesia Rating Scale (UDysRS). He served as the Co-Director of the MDS Clinical Outcome Assessment program overseeing the development and implementation of multiple rating scales. Dr. Stebbins serves as advisor to the MJFF, CHDI Foundation, Critical Path for Parkinson's Consortium, Huntington's Disease Regulatory Science Consortium, Huntington Study Group and multiple industry partners. He has lectured internationally and is the author or co-author of more that 300 peer-reviewed articles, reviews, books, book chapters, and edited volumes.
Associated Grants
-
-
Measuring Quality of Life in People with Parkinson’s Disease: State of the Art and Areas for Development
2023
-
-
Unified Dyskinesia Rating Scale: Application for FDA Designation as a Preferred Scale for Assessing Dyskinesia in Parkinson’s Disease
2015